ADC Therapeutics adctherapeutics.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

ADC Therapeutics (ADCT) is an oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major solid and hematological cancers. The Company's ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to surface antigens on particular tumor cells with a novel class of highly potent pyrrolobenzodiazepine (PBD)-based warheads. The Company has access to warhead and linker chemistries via agreements with S...Show all

ADC Therapeutics (ADCT) is an oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major solid and hematological cancers. The Company's ADCs are highly targeted drug constructs...Show all

Company (Alive / Active)

Phone: +41 21 653 02 00

Fax:

Route de la Corniche 3B

Epalinges, CH-1066
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ADC Therapeutics $475M Oct 23, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ADC Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pyrrolobenzodiazepine—antibody conjugates Oct 10, 2014 May 01, 2018 Patent
Pyrrolobenzodiazepine-antibody conjugates Oct 10, 2014 Apr 24, 2018 Patent
Pyrrolobenzodiazepine-antibody conjugates Oct 11, 2013 Apr 03, 2018 Patent
Pyrrolobenzodiazepine-antibody conjugates Oct 11, 2013 Apr 03, 2018 Patent
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates Oct 11, 2013 Mar 20, 2018 Patent
See all 219 patents